• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌与肝硬化之间的关系。

Relationship between hepatocellular carcinoma and cirrhosis.

作者信息

Kew M C, Popper H

出版信息

Semin Liver Dis. 1984 May;4(2):136-46. doi: 10.1055/s-2008-1040653.

DOI:10.1055/s-2008-1040653
PMID:6087459
Abstract

The precise nature of the relationship between cirrhosis and HCC remains to be elucidated. However, it seems likely that no single explanation will cover the various forms the association takes in different parts of the world. In the high HCC incidence regions of sub- Saharan Africa and the Far East, an etiology common to the two disorders, HBV and possibly other hepatitis viruses, seems to account for the majority of cases. The role of aflatoxin in these areas is uncertain because it appears not to cause cirrhosis in man. In populations in which HCC is uncommon, alcoholic cirrhosis is the most frequent association of HCC. There is no convincing evidence to support a shared etiology in this situation because alcohol has not thus far been proved to be directly oncogenic for the liver. Possibly, cirrhosis renders the hepatocytes more susceptible to environmental carcinogenic factors. The same explanation may apply to hemochromatosis. There is at present little evidence for the postulate that HCC is an inevitable consequence of the hyperplasia of cirrhosis.

摘要

肝硬化与肝癌之间关系的确切性质仍有待阐明。然而,似乎没有单一的解释能够涵盖在世界不同地区这种关联所呈现的各种形式。在撒哈拉以南非洲和远东地区肝癌高发区,这两种疾病共有的病因,即乙肝病毒以及可能的其他肝炎病毒,似乎是大多数病例的病因。黄曲霉毒素在这些地区的作用尚不确定,因为它似乎不会在人类中引发肝硬化。在肝癌不常见的人群中,酒精性肝硬化是与肝癌最常见的关联。在这种情况下,没有令人信服的证据支持共同病因的说法,因为到目前为止,酒精尚未被证明对肝脏具有直接致癌性。可能是肝硬化使肝细胞更容易受到环境致癌因素的影响。同样的解释可能适用于血色素沉着症。目前几乎没有证据支持肝癌是肝硬化增生必然结果这一假设。

相似文献

1
Relationship between hepatocellular carcinoma and cirrhosis.肝细胞癌与肝硬化之间的关系。
Semin Liver Dis. 1984 May;4(2):136-46. doi: 10.1055/s-2008-1040653.
2
Etiology of hepatocellular carcinoma in Africa.非洲肝细胞癌的病因
IARC Sci Publ. 1984(63):89-95.
3
Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.乙型肝炎病毒与黄曲霉毒素在肝细胞癌中的协同作用。
IARC Sci Publ. 1984(63):167-79.
4
Hepatocellular carcinoma: molecular biology, etiology and animal models.肝细胞癌:分子生物学、病因学及动物模型
Gastroenterol Clin North Am. 1987 Dec;16(4):575-90.
5
[Role of combined etiology (alcohol and B virus) in the development of hepatocarcinoma in subjects with liver cirrhosis].[联合病因(酒精与B病毒)在肝硬化患者肝癌发生中的作用]
Recenti Prog Med. 1989 May;80(5):233-6.
6
Hepatocarcinogenesis.肝癌发生
Trop Gastroenterol. 1990 Jan-Mar;11(1):9-24.
7
Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.肯尼亚的乙型肝炎病毒、肝细胞癌和肝硬化
East Afr Med J. 1993 Apr;70(4 Suppl):34-6.
8
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.意大利有肝硬化和无肝硬化的肝细胞癌患者的病因
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6.
9
[Prevention of cirrhosis is the best measure against hepatocellular cancer].预防肝硬化是对抗肝细胞癌的最佳措施。
Lakartidningen. 1999 Jan 27;96(4):338-41.
10
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.糖尿病在肝细胞癌中的作用:一项针对美国退伍军人的病例对照研究。
Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x.

引用本文的文献

1
Liposomal Drug Delivery of Leaf Extract: In-Vivo Hepatoprotective Effects.叶提取物的脂质体药物递送:体内保肝作用。
Nanomaterials (Basel). 2022 Jun 30;12(13):2262. doi: 10.3390/nano12132262.
2
Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.不同危险因素导致的肝细胞癌的差异剪接调控。
BMC Med Genomics. 2019 Dec 20;12(Suppl 8):175. doi: 10.1186/s12920-019-0635-z.
3
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma.
用于将姜黄素衍生物选择性递送至肝细胞癌的去唾液酸糖蛋白受体导向纳米颗粒的研发
Heliyon. 2018 Dec 22;4(12):e01071. doi: 10.1016/j.heliyon.2018.e01071. eCollection 2018 Dec.
4
Astaxanthin Ameliorates Hepatic Damage and Oxidative Stress in Carbon Tetrachloride-administered Rats.虾青素改善四氯化碳诱导的大鼠肝损伤和氧化应激
Pharmacognosy Res. 2017 Dec;9(Suppl 1):S84-S91. doi: 10.4103/pr.pr_26_17.
5
AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.AROS是无肝硬化肝细胞癌肿瘤侵袭性的重要生物标志物。
J Korean Med Sci. 2015 Sep;30(9):1253-9. doi: 10.3346/jkms.2015.30.9.1253. Epub 2015 Aug 13.
6
Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis.慢性丙型肝炎病毒诱导的肝损伤和肝硬化中的肝细胞更新
Gastroenterol Res Pract. 2015;2015:654105. doi: 10.1155/2015/654105. Epub 2015 Mar 29.
7
Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats.人参提取物和人参皂苷 Rb1 可减轻大鼠四氯化碳诱导的肝纤维化。
BMC Complement Altern Med. 2014 Oct 25;14:415. doi: 10.1186/1472-6882-14-415.
8
Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.在转基因小鼠中,miR-483-5p/3p的过表达通过抑制转化生长因子-β刺激的肝星状细胞协同抑制小鼠肝纤维化。
J Cell Mol Med. 2014 Jun;18(6):966-74. doi: 10.1111/jcmm.12293. Epub 2014 May 6.
9
The role of cirrhosis in the etiology of hepatocellular carcinoma.肝硬化在肝细胞癌病因学中的作用。
J Gastrointest Cancer. 2014 Mar;45(1):12-21. doi: 10.1007/s12029-013-9556-9.
10
Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.肝切除术后酒精摄入与非B型或非C型肝细胞癌复发:一项倾向评分分析
J Gastroenterol. 2014 Sep;49(9):1352-61. doi: 10.1007/s00535-013-0899-6. Epub 2013 Oct 18.